Literature DB >> 107359

Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro.

I C Summerhayes, L M Franks.   

Abstract

Neoplastic transformation of C57BL/lcrf-a' mouse bladder epithelium was induced in long-term primary cultures by a single 24-hour treatment with 7,12-dimethylbenz[a]anthracene on day 2 of culture. Transformed foci appeared earlier (40--60 days) and at a higher frequency (28%) in cultures from old donors (28--30 mo) compared with 100 days and 0.9% in cultures from young adult donors (5--7 mo). After transplantation into syngeneic mice, transformed cells produced carcinomas. Spontaneous epithelial transformation occurred in dimethyl sulfoxide-treated old cultures after the same interval (40--60 days) as in the carcinogen-treated cultures but at a lower frequency (5.3%). Spontaneous epithelial transformation did not occur in cultures from young donors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107359

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  56 in total

1.  CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.

Authors:  Yuji Sato; Jennifer K Bolzenius; Abdallah M Eteleeb; Xinming Su; Christopher A Maher; Jennifer K Sehn; Vivek K Arora
Journal:  JCI Insight       Date:  2018-12-06

2.  An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.

Authors:  Shizhang Ling; Xiaofei Chang; Luciana Schultz; Thomas K Lee; Alcides Chaux; Luigi Marchionni; George J Netto; David Sidransky; David M Berman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

3.  The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.

Authors:  David Coe; Caroline Addey; Matthew White; Elizabeth Simpson; Julian Dyson; Jian-Guo Chai
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

4.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

5.  Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.

Authors:  Sonia Domingos-Pereira; Valérie Cesson; Mathieu F Chevalier; Laurent Derré; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

6.  Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Authors:  David A Zaharoff; Benjamin S Hoffman; H Brooks Hooper; Compton J Benjamin; Kiranpreet K Khurana; Kenneth W Hance; Connie J Rogers; Peter A Pinto; Jeffrey Schlom; John W Greiner
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

7.  Irreversibility of cellular aging and neoplastic transformation: a clonal analysis.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer.

Authors:  Sean G Smith; Bhanu Prasanth Koppolu; Sruthi Ravindranathan; Samantha L Kurtz; Lirong Yang; Matthew D Katz; David A Zaharoff
Journal:  Cancer Immunol Immunother       Date:  2015-03-10       Impact factor: 6.968

9.  Establishment and characterization of long-term primary mouse urothelial cell cultures.

Authors:  T H van der Kwast; H van Rooy; A H Mulder
Journal:  Urol Res       Date:  1989

10.  Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.

Authors:  Y Luo; R Han; D P Evanoff; X Chen
Journal:  Clin Exp Immunol       Date:  2010-02-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.